Abstract:Background: Bleeding peptic ulcers is among the leading cause of hospitalization. The reported mortality approaches 10%. We reviewed our prospective database to identify risk factors for in-hospital mortality in patients with bleeding peptic ulcers. Patients & Method: We prospectively collected data on patients with bleeding peptic ulcers since 1993. The parameters collected included the patient's demographics, the characteristics of the peptic ulcer, treatment received and the outcome. We used a univariate followed by multivariate analyses to identify factors for in-hospital deaths. Results: From 1993 to 2003, 9032 patients presented to our endoscopy center with bleeding peptic ulcers. The overall mortality is 4.6%, and the overall rate of rebleeding is 4.9%. 3220 patients had bleeding peptic ulcers with endoscopic stigmata of active bleeding, visible vessel or adherent clot. 229 of them died during hospitalization (7.1%). From multivariate analysis, age > 70, the presence of comorbidities, hematemesis upon presentation, initial systolic BP < 100 mm Hg, in-hospital ulcer bleeding, non-H pylori related ulcer, rebleeding and need of surgery were significant predictors for mortality. (Table 1) Conclusions: For high risk bleeding peptic ulcers, elderly, presence of comorbidities, hematemesis, shock, in-hospital bleeding and ulcer rebleeding are significant predictors for mortality. HP related ulcers are associated with a lower mortality. Table 1comparison of clinical and endoscopic parameters between survivors & non-survivors Variables Survivor (n = 2991) Non-survivor (n = 229) Univariate analysis p value Univariate analysis OR (95% CI) Mult-variate analysis p value Mult-variate analysis OR (95% CI) Age > 70 1213 134 <0.01† 2.07 (1.57-2.71) 0.01 1.47 (1.09-1.98) Male 2046 (68.4%) 157 (68.6%) 0.962 Co-morbidities 1628 (54.4%) 202 (88.2%) <0.001† 6.26 (4.17-9.42) <0.001 4.12 (2.65-6.39) Ischemic heart disease 358 (11.9%) 49 (21.4%) <0.001† 2.00 (1.43-2.80) NSAID user 1029 (34.4%) 78 (34.1%) 0.916 0.99 (0.74-1.31) Aspirin user 309 (10.3%) 27 (11.8%) 0.486 1.16 (0.76-1.76) H pylori positive 1187 (39.7%) 20 (8.7%) <0.001† 0.15 (0.09-0.23) <0.001 0.20 (0.13-0.33) Past history of peptic ulcer 1145 (38.3%) 47 (20.5%) <0.001† 0.42 (0.30-0.58) Hematemesis 435 (14.5%) 55 (24.0%) <0.001† 1.86 (1.35-2.56) 0.039 1.45 (1.02-2.05) SBP < 100 mm Hg 554 (18.5%) 90 (39.3%) <0.001† 2.85 (2.15-3.77) <0.001 2.24 (1.65-3.05) Hb < 8 g/dl 949 (31.7%) 100 (43.7%) <0.001† 1.67 (1.27-2.19) Size of ulcer > 2 cm 553 (18.5%) 56 (24.5%) 0.026† 1.43 (1.04-1.96) In-hospital bleeder 327 (10.9%) 90 (39.3%) <0.001† 5.28 (3.95-7.04) <0.001 2.46 (1.78-3.39) Gastric ulcer 1192 (39.9%) 108 (47.2%) 0.030† 1.35 (1.03-1.76) Posterio-inferior DU 90 (3.0%) 5 (2.2%) 0.477 0.72 (0.29-1.79) Lesser curve GU 46 (1.5%) 5 (2.2%) 0.451 1.43 (0.56-3.63) Active spurter on primary OGD 224 (7.5%) 19 (8.3%) 0.656 1.12 (0.69-1.82) Rebleeding 237 (7.9%) 47 (20.5%) <0.001† 3.00 (2.12-4.25) 0.016 1.63 (1.09-2.41) Surgery 118 (3.9%) 42 (18.3%) <0.001† 5.47 (3.73-8.01) <0.001 4.60 (2.95-7.19) Open table in a new tab

Nature and Treatment Outcomes of Bleeding Post-Bulbar Duodenal Ulcers

Peptic Ulcer Bleeding in China: A Multicenter Endoscopic Survey of 1006 Patients

A Novel Strategy of Combining Abdominal Surgery and Endoscopy for the Quick Hemostasis of Acute Duodenal Ulcer Bleeding: a Case Report

THE CAUSES OF ADVERSE TREATMENT RESULTS AND THE WAYS OF THEIR ELIMINATION IN BLEEDING FROM CHRONIC GASTRODUODENAL ULCERS

Urgent Endoscopy Improves Hemostasis in Patients with Upper Gastrointestinal Bleeding Following Biliary-pancreatic Surgery: A Retrospective Analysis.

Impact of peptic ulcer bleeding on the in-hospital outcomes of cirrhotic patients with acute gastrointestinal bleeding: an international multicenter study

Pathogenesis,prevention and treatment of upper gastrointestinal hemorrhage after pancreatoduodenectomy

Delayed bleeding after endoscopic submucosal dissection for non-ampullary superficial duodenal neoplasias might be prevented by prophylactic endoscopic closure: analysis of risk factors

The Prediction of Mortality in Bleeding Peptic Ulcers Treated with Therapeutic Endoscopy - Lesson Learnt from 3000 Patients

Results of surgical treatment on post-pancreaticoduodenectomy hemorrhage

High risk stigmata and treatment strategy for acute lower gastrointestinal bleeding: a nationwide study in Japan

Management of bleeding peptic duodenal ulcer refractory to endoscopic treatment: surgery or transcatheter arterial embolization as first-line therapy? A retrospective single-center study and systematic review

Clinical characteristics of acute non-varicose upper gastrointestinal bleeding and the effect of endoscopic hemostasis

Cause and Treatment of Gastrointestinal Hemorrhage after Pancreaticoduodenectomy

Characteristics of Bleeding Peptic Ulcers and the Outcome after Endoscopic Therapy at a Tertiary Care Centre of Pakistan

Clinical characteristics and risk factors for rebleeding in uremic patients with obscure gastrointestinal bleeding undergoing deep enteroscopy: A multi-center retrospective study in Taiwan

Postoperative Bleeding Risk after Gastric Endoscopic Submucosal Dissection in Patients Receiving a P2Y12 Receptor Antagonist

Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases

Factors influencing re-bleeding after trans-arterial embolization for endoscopically unmanageable peptic ulcer bleeding

Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding

Challenges in the Management of Acute Peptic Ulcer Bleeding